TABLE 3.

Imaging Parameters Obtained by 68Ga-DOTATOC PET/CT Analysis of Primary Tumors, Lymph Node Metastases, and Distant Metastases

ParameterMean ± SDMedianRangeP*
SUVmax
 Primary tumor24.10 ± 19.5116.604.78–88.31T vs. N = 0.4559
 Lymph node metastases27.77 ± 20.5121.513.00–82.04N vs. M = 0.2256
 Distant metastases34.99 ± 27.8928.263.98–115.55M vs. T = 0.0573
SUVmean
 Primary tumor8.70 ± 7.536.863.29–42.72T vs. N = 0.8507
 Lymph node metastases8.38 ± 4.108.051.41–18.31N vs. M = 0.0056
 Distant metastases13.72 ± 9.9012.441.68–43.41M vs. T = 0.0170
CoV
 Primary tumor0.49 ± 0.200.510.17–0.95T vs. N = 0.1730
 Lymph node metastases0.57 ± 0.260.580.10–1.07N vs. M = 0.0253
 Distant metastases0.44 ± 0.200.390.14–1.00M vs. T = 0.3260
RETV (mL)
 Primary tumor25.07 ± 34.7510.692.43–178.24T vs. N = 0.0879
 Lymph node metastases13.26 ± 17.427.040.80–82.04N vs. M = 0.0044
 Distant metastases33.68 ± 36.0418.972.11–136.25M vs. T = 0.2972
TLRE (g)
 Primary tumor309.83 ± 813.8363.2915.80–4766.19T vs. N = 0.2616
 Lymph node metastases142.56 ± 195.3471.252.99–766.21N vs. M = 0.0028
 Distant metastases601.23 ± 816.25258.383.56–2908.85M vs. T = 0.1268
  • * Unpaired t test (T = primary tumor; N = lymph node metastases; M = distant metastases).